Tangential Flow Filtration(TFF) System
Jump Pump
FIT Integrity Tester
High Pressure Homogenizers
Microfluidics
News
Challenge IM Unveils Next-Generation Capsule Filters: Redefining Efficiency, Convenience, and Reliability with "Core" Innovation
Season’s Greetings from Challenge IM
Challenge IM · Delivering Excellence
Professionalism earns trust. Strength defines scale.
— A leading provider of specialized biopharmaceutical membrane filtration solutions.
Challenge IM Showcases Innovation at BioProcess International 2025
Boston, MA – September 18, 2025 – At the conclusion of BioProcess International (BPI) 2025, the world’s premier event for biopharmaceutical process development and manufacturing, China-based Challenge IM shone on the exhibition floor with its innovative membrane filtration and bioprocessing equipment. The company attracted strong attention from delegations from the United States, the United Kingdom, Korea, Japan, and other countries, highlighting the rising influence of “Made in China” in the global pharmaceutical equipment market.
Discover Next-Gen Automated TFF Systems at BPI Boston – Booth #1518
We’re excited to unveil our next-generation automated TFF system—the Challenge Dream AUTO—at BPI Boston (Booth #1518, Sep 15–18, 2025, Hynes Convention Center).
Meet us at BIOCHINA 2025!
Meet us at BIOCHINA 2025! Challenge IM is gearing up for Asia’s premier biotech event, and we’d love to connect with partners, investors, and innovators.
- Explore our fully automated tangential flow filtration systems
- Discuss collaboration opportunities
- Stay ahead of industry trends
- Booth: C1-111-112
- March 12-15, Suzhou
Reach out at service@challengeim.com. See you at BIOCHINA 2025!
Chengdu UCELLO Biotech’s UC101 Receives FDA IND Approval, Supported by Challenge IM’s Cutting-Edge Ultrafiltration Technology
Chengdu, January 2025– Chengdu UCELLO Biotech Co., Ltd. has recently announced that its self-developed CD19-targeted chimeric antigen receptor (CAR) allogeneic universal T cell therapy, UC101, has received approval from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application on January 11, 2025.
Challenge Intelligent Manufacturing Achieves "High-Tech Enterprise" Certification, Embarking on a New Journey of Innovation and Development
Beijing, January 9, 2024 – Challenge Intelligent Manufacturing (Beijing) Technology Co., Ltd. proudly announces its certification as a "High-Tech Enterprise" by Beijing authorities, following the fourth batch of certified high-tech enterprises in 2023.